Laure Saumet

Montpellier, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience.

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 16, 2026

Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial.

Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial.

Journal: British journal of cancer
Published: June 02, 2025

Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France Experience.

Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France Experience.

Journal: Pediatric blood & cancer
Published: October 03, 2024

Radiotherapy in Ewing sarcomas

Radiotherapy in Ewing sarcomas

Journal: Bulletin du cancer
Published: June 25, 2024

Li-Fraumeni-associated osteosarcomas: The French experience.

Li-Fraumeni-associated osteosarcomas: The French experience.

Journal: Pediatric blood & cancer
Published: June 11, 2024

Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?

Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?

Journal: British journal of cancer
Published: March 06, 2024

Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study.

Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study.

Journal: JAMA network open
Published: July 03, 2023

Outcome and late effects of patients treated for childhood vaginal malignant germ cell tumors.

Outcome and late effects of patients treated for childhood vaginal malignant germ cell tumors.

Journal: Pediatric blood & cancer
Published: July 03, 2023

Oral vinorelbine in young patients with desmoid-type fibromatosis.

Oral vinorelbine in young patients with desmoid-type fibromatosis.

Journal: Tumori
Published: April 28, 2023

Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.

Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.

Journal: International journal of cancer
Published: June 01, 2022

Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study.

Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study.

Journal: International journal of cardiology
Published: October 04, 2021

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?

Journal: Cancers
Published: February 24, 2021
Showing 1-12 of 31

Last Updated: 09/26/2026